Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Merck & Co., Inc.

NYSE

Market Cap.

327.97B

Avg. Volume

8.2M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Merck & Co., Inc.!

Still processing it, give me a bit more time...

Merck & Co., Inc. News

Merck & Co., Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareDrug Manufacturers - General
merck.com

About Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Merck & Co., Inc. Earnings & Revenue

Merck & Co., Inc. Financials

Table Compare

Compare MRK metrics with:

   

Earnings & Growth

MRK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MRK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MRK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MRK

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Merck & Co., Inc. Income

Merck & Co., Inc. Balance Sheet

Merck & Co., Inc. Cash Flow

Merck & Co., Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Merck & Co., Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.0000

Payment DateDividendFrequency
2024-04-050.77Quarterly
2024-01-080.77Quarterly
2023-10-060.73Quarterly
2023-07-100.73Quarterly
2023-04-100.73Quarterly

Historical Market Cap

Shares Outstanding

Merck & Co., Inc. Executives

NameRole
Mr. Robert M. Davis J.D.Chairman, President & Chief Executive Officer
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President & President of Merck Research Laboratories
Ms. Caroline LitchfieldExecutive Vice President & Chief Financial Officer
Ms. Jennifer L. ZacharyExecutive Vice President & General Counsel
Mr. Sanat ChattopadhyayExecutive Vice President & President of Merck Manufacturing Division
NameRoleGenderDate of BirthPay
Mr. Robert M. Davis J.D.Chairman, President & Chief Executive OfficerMale19675.57M
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President & President of Merck Research Laboratories19633.61M
Ms. Caroline LitchfieldExecutive Vice President & Chief Financial OfficerFemale19693.09M
Ms. Jennifer L. ZacharyExecutive Vice President & General CounselFemale19782.73M
Mr. Sanat ChattopadhyayExecutive Vice President & President of Merck Manufacturing DivisionMale19602.49M

Merck & Co., Inc. Insider Trades

Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares516
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionDisposed
TypeF-InKind
Shares255
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares1530
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionDisposed
TypeF-InKind
Shares590
Date4 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares612
DateNameRoleTransactionTypeShares
3 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt516
3 MaySmart DaltonSVP Fin. - Global ControllerDisposedF-InKind255
3 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt1530
3 MaySmart DaltonSVP Fin. - Global ControllerDisposedF-InKind590
4 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt612

Discover More

Streamlined Academy

Merck & Co., Inc.

NYSE

Market Cap.

327.97B

Avg. Volume

8.2M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Merck & Co., Inc. News

Merck & Co., Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Merck & Co., Inc. Earnings & Revenue

Merck & Co., Inc. Income

Merck & Co., Inc. Balance Sheet

Merck & Co., Inc. Cash Flow

Merck & Co., Inc. Financials Over Time

Merck & Co., Inc. Executives

NameRole
Mr. Robert M. Davis J.D.Chairman, President & Chief Executive Officer
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President & President of Merck Research Laboratories
Ms. Caroline LitchfieldExecutive Vice President & Chief Financial Officer
Ms. Jennifer L. ZacharyExecutive Vice President & General Counsel
Mr. Sanat ChattopadhyayExecutive Vice President & President of Merck Manufacturing Division
NameRoleGenderDate of BirthPay
Mr. Robert M. Davis J.D.Chairman, President & Chief Executive OfficerMale19675.57M
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President & President of Merck Research Laboratories19633.61M
Ms. Caroline LitchfieldExecutive Vice President & Chief Financial OfficerFemale19693.09M
Ms. Jennifer L. ZacharyExecutive Vice President & General CounselFemale19782.73M
Mr. Sanat ChattopadhyayExecutive Vice President & President of Merck Manufacturing DivisionMale19602.49M

Merck & Co., Inc. Insider Trades

Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares516
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionDisposed
TypeF-InKind
Shares255
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares1530
Date3 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionDisposed
TypeF-InKind
Shares590
Date4 May
NameSmart Dalton
RoleSVP Fin. - Global Controller
TransactionAcquired
TypeM-Exempt
Shares612
DateNameRoleTransactionTypeShares
3 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt516
3 MaySmart DaltonSVP Fin. - Global ControllerDisposedF-InKind255
3 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt1530
3 MaySmart DaltonSVP Fin. - Global ControllerDisposedF-InKind590
4 MaySmart DaltonSVP Fin. - Global ControllerAcquiredM-Exempt612

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
merck.com

About Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Merck & Co., Inc.!

Still processing it, give me a bit more time...

Merck & Co., Inc. Financials

Table Compare

Compare MRK metrics with:

   

Earnings & Growth

MRK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MRK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MRK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MRK

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Merck & Co., Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.0000

Payment DateDividendFrequency
2024-04-050.77Quarterly
2024-01-080.77Quarterly
2023-10-060.73Quarterly
2023-07-100.73Quarterly
2023-04-100.73Quarterly

Merck & Co., Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More